California State Teachers Retirement System Biotechnology

California State Teachers Retirement System

$84.1 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TSHA Taysha Gene Therapies, Inc.	$110M	$25,000 0.0% of portfolio	12,635	Q3 2024 Added 9.01%
CCCC C4 Therapeutics, Inc.	$231M	$24,000 0.0% of portfolio	4,248	Q2 2024 New
ABSI Absci Corp	$280M	$22,000 0.0% of portfolio	5,787	Q2 2024 New
STRO Sutro Biopharma, Inc.	$180M	$20,000 0.0% of portfolio	5,932	Q2 2024 Reduced 3.14%
BMEA Biomea Fusion, Inc.	$208M	$20,000 0.0% of portfolio	2,002	Q3 2024 Reduced 92.01%
AKBA Akebia Therapeutics, Inc.	$349M	$19,000 0.0% of portfolio	15,073	Q2 2024 New
VNDA Vanda Pharmaceuticals Inc.	$288M	$19,000 0.0% of portfolio	4,130	Q2 2024 Reduced 27.29%
VYGR Voyager Therapeutics, Inc.	$240M	$19,000 0.0% of portfolio	3,333	Q2 2024 Reduced 15.77%
INZY Inozyme Pharma, Inc.	$140M	$19,000 0.0% of portfolio	3,746	Q2 2024 Reduced 21.94%
ALDX Aldeyra Therapeutics, Inc.	$249M	$19,000 0.0% of portfolio	3,610	Q2 2024 Reduced 22.9%
ADGI Adagio Therapeutics, Inc.	$505M	$19,000 0.0% of portfolio	5,747	Q2 2024 New
THRD Third Harmonic Bio, Inc.	$520M	$19,000 0.0% of portfolio	1,437	Q2 2024 Reduced 26.65%
LRMR Larimar Therapeutics, Inc.	$344M	$19,000 0.0% of portfolio	3,048	Q2 2024 Added 16.47%
IGMS Igm Biosciences, Inc.	$293M	$18,000 0.0% of portfolio	1,099	Q2 2024 Reduced 17.74%
AVIR Atea Pharmaceuticals, Inc.	$276M	$18,000 0.0% of portfolio	5,591	Q2 2024 Reduced 27.46%
OCGN Ocugen, Inc.	$217M	$18,000 0.0% of portfolio	18,540	Q2 2024 New
ADCT Adc Therapeutics Sa	$206M	$18,000 0.0% of portfolio	5,994	Q3 2024 Added 18.15%
NKTX Nkarta, Inc.	$131M	$17,000 0.0% of portfolio	3,834	Q2 2024 Added 26.12%
FHTX Foghorn Therapeutics Inc.	$366M	$17,000 0.0% of portfolio	1,830	Q2 2024 Reduced 10.47%
FULC Fulcrum Therapeutics, Inc.	$173M	$16,000 0.0% of portfolio	4,496	Q2 2024 New
HRTX Heron Therapeutics, Inc.	$147M	$16,000 0.0% of portfolio	8,507	Q2 2024 Reduced 18.27%
NKTR Nektar Therapeutics	$219M	$16,000 0.0% of portfolio	12,936	Q2 2024 New
OMER Omeros Corp	$436M	$16,000 0.0% of portfolio	4,053	Q2 2024 Reduced 33.79%
GLUE Monte Rosa Therapeutics, Inc.	$396M	$16,000 0.0% of portfolio	3,049	Q3 2024 Added 38.09%
TSVT 2seventy Bio, Inc.	$148M	$16,000 0.0% of portfolio	3,541	Q2 2024 Reduced 29.88%
ENOB Enochian Biosciences Inc	$244M	$16,000 0.0% of portfolio	3,533	Q2 2024 New
CABA Cabaletta Bio, Inc.	$115M	$15,000 0.0% of portfolio	3,338	Q3 2024 Reduced 90.13%
CDXS Codexis, Inc.	$245M	$15,000 0.0% of portfolio	5,061	Q2 2024 Reduced 27.8%
ENTA Enanta Pharmaceuticals Inc	$210M	$15,000 0.0% of portfolio	1,456	Q2 2024 Reduced 28.52%
MRSN Mersana Therapeutics, Inc.	$245M	$15,000 0.0% of portfolio	8,220	Q2 2024 Reduced 26.24%
ZNTL Zentalis Pharmaceuticals, Inc.	$225M	$15,000 0.0% of portfolio	4,141	Q3 2024 Reduced 92.11%
KMPH Kempharm, Inc	$170M	$15,000 0.0% of portfolio	3,048	Q2 2024 Reduced 16.65%
XOMA Xoma Corp	$342M	$15,000 0.0% of portfolio	582	Q2 2024 Reduced 20.82%
MGNX Macrogenics Inc	$234M	$14,000 0.0% of portfolio	4,454	Q3 2024 Reduced 90.55%
PSTX Poseida Therapeutics, Inc.	$275M	$14,000 0.0% of portfolio	4,975	Q2 2024 Reduced 27.2%
PROK Prokidney Corp Ord Shs Cl A(Cy	$132M	$14,000 0.0% of portfolio	7,659	Q3 2024 Added 67.67%
TRVI Trevi Therapeutics, Inc.	$164M	$14,000 0.0% of portfolio	4,255	Q2 2024 Added 0.42%
ATOS Atossa Therapeutics, Inc.	$173M	$13,000 0.0% of portfolio	9,165	Q2 2024 New
CMPX Compass Therapeutics, Inc.	$161M	$13,000 0.0% of portfolio	7,390	Q2 2024 Reduced 19.46%
TCRX T Scan Therapeutics, Inc.	$100M	$13,000 0.0% of portfolio	2,782	Q2 2024 New
CDXC Chroma Dex Corp.	$492M	$12,000 0.0% of portfolio	3,548	Q2 2024 New
BDTX Black Diamond Therapeutics, Inc.	$99.6M	$12,000 0.0% of portfolio	2,940	Q3 2024 Added 9.25%
DSGN Design Therapeutics, Inc.	$336M	$12,000 0.0% of portfolio	2,275	Q2 2024 Reduced 30.94%
PYXS Pyxis Oncology, Inc.	$146M	$12,000 0.0% of portfolio	3,539	Q2 2024 New
MGTX Meira G Tx Holdings PLC	$299M	$11,000 0.0% of portfolio	2,811	Q2 2024 Reduced 14.27%
XBIT X Biotech Inc.	$212M	$11,000 0.0% of portfolio	1,482	Q3 2024 Added 10.51%
CRBU Caribou Biosciences, Inc.	$127M	$11,000 0.0% of portfolio	5,961	Q2 2024 Reduced 27.6%
ELYM Eliem Therapeutics, Inc.	$109M	$11,000 0.0% of portfolio	2,169	Q3 2024 Added 310.8%
VRCA Verrica Pharmaceuticals Inc.	$327M	$10,000 0.0% of portfolio	1,372	Q2 2024 Reduced 34.64%
NAUT Nautilus Biotechnology, Inc.	$307M	$10,000 0.0% of portfolio	3,530	Q2 2024 Reduced 30.44%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.